Alzheimer's Disease: Neuroimaging

Alzheimer's disease (AD) is a chronic neurodegenerative disease. Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

September 19, 2020

Corticobasal manifestations of Creutzfeldt-Jakob disease with D178N-homozygous 129M genotype

Prion
Yumeng HuangHuidong Tang
September 21, 2020

Cerebrovascular pathology in Alzheimer's disease: Hopes and gaps

Psychiatry Research. Neuroimaging
Atef Badji, Eric Westman
September 17, 2020

Hippocampal blood-brain barrier permeability is related to the APOE4 mutation status of elderly individuals without dementia

Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
Won-Jin MoonSeol-Heui Han
September 16, 2020
Review
Open Access

Alzheimer's disease: natural products as inhibitors of neuroinflammation

Inflammopharmacology
Olumayokun A Olajide, Satyajit D Sarker
September 21, 2020

AlzRiskMR database: an online database for the impact of exposure factors on Alzheimer's disease

Briefings in Bioinformatics
Zhe WangHong-Fang Ji
September 18, 2020
Open Access

Focal alteration of the intraretinal layers in neurodegenerative disorders

Annals of Eye Science
Shriya AirenHong Jiang
September 18, 2020

Multi-omic comparison of Alzheimer's variants in human ESC-derived microglia reveals convergence at APOE

The Journal of Experimental Medicine
Tongfei LiuHuaxi Xu
September 19, 2020

Alzheimer's-related cerebrovascular disease in Down syndrome

Annals of Neurology
Patrick J LaoAdam M Brickman
September 19, 2020

TNF receptors are associated with tau pathology and conversion to Alzheimer's dementia in subjects with mild cognitive impairment

Neuroscience Letters
Aonan ZhaoAlzheimer’s Disease Neuroimaging Initiative
September 18, 2020

Diabetic Theory in Anti-Alzheimer's Drug Research and Development. Part 2: Therapeutic Potential of cAMP-Specific Phosphodiesterase Inhibitors

Current Medicinal Chemistry
Agnieszka JankowskaGrażyna Chłoń-Rzepa
September 20, 2020

Discordant Alzheimer's neurodegenerative biomarkers and their clinical outcomes

Annals of Clinical and Translational Neurology
Yu GuoAlzheimer's Disease Neuroimaging Initiative
September 4, 2020

A cross-national study of depression in preclinical dementia: A COSMIC collaboration study

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Sophie Carlesfor Cohort Studies of Memory in an International Consortium (COSMIC)
September 18, 2020

Amyloid Targeting 'Artificial Chaperone' Impairs Oligomer Mediated Neuronal Damage and Mitochondrial Dysfunction Associated with Alzheimer Disease

ACS Chemical Neuroscience
Subrata MondalParameswar Krishnan Iyer
September 16, 2020

Amyloid, tau and risk of Alzheimer's disease: a Mendelian randomization study

European Journal of Epidemiology
Chris Ho Ching YeungC Mary Schooling

Sign up to follow this feed and discover related papers.

Related Feeds

AFM in situ DNA

AFM in situ DNA describes in situ analysis (or study) of DNA using atomic force microscopy. Discover the latest research on AFM in situ DNA here.

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

© 2020 Meta ULC. All rights reserved
/feed-previews/alzheimers-disease-neuroimaging/a5242adb-290c-4f90-bd45-b0d1bbfc9166